Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Jiangsu HengRui Medicine Co., Ltd.
Scientific Title
A Phase 1 Multi-Country, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-A1811 in HER2 Expressing or Mutated Advanced Malignant Solid Tumor Subjects